Press-release for stocks for evgn

Prices are updated after-hours

| -71.21% | O: 1.15% H: 1.13% C: -3.77%
drug trial

Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2021
Published: 2021-10-27 (Crawled : 12:00) - biospace.com/
EVGN | $0.7 -13.64% 63K

| -71.21% | O: 1.15% H: 1.13% C: -3.77%
financial results results announcement

56%

44%

INVO | $1.76 131.58% 56.82% 230M

SINT | $0.0365 59.39% 37.26% 470M

WISA 4 | $9.19 50.66% 33.7% 65M

EDBL | News | $6.73 47.91% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 640K

TCON | $2.33 36.26% 26.61% 2M

TIRX | $0.48 6.43% 24.58% 4.8M

KZIA | $0.38 30.58% 23.42% 300K

VNDA | News | $5.23 29.14% 22.56% 24M

ATNF | $1.91 29.05% 22.51% 310K

Save your searches and get alerts when important news are released.